Search

everythinglearnresearchcommunity

for

Search:↓

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Mogamulizumab can cause hair loss and skin rashes.

Omalizumab may cause hair loss.

Injecting patients' own PRP into their thyroid improved thyroid function and symptoms in most hypothyroidism cases.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Cetuximab can cause unusual hair growth and hair loss.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Antibody treatments show promise for hair loss but need more research.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Graves' disease is a common cause of hyperthyroidism, mainly in women, treated with medication, iodine, or surgery, with varying outcomes.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.